Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
Reel/Frame: | 026917/0343 | |
| Pages: | 16 |
| | Recorded: | 09/16/2011 | | |
Attorney Dkt #: | PAT052073 |
Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
Total properties:
1
|
|
Patent #:
|
|
Issue Dt:
|
10/16/2012
|
Application #:
|
12375074
|
Filing Dt:
|
05/18/2009
|
Publication #:
|
|
Pub Dt:
|
01/14/2010
| | | | |
Title:
|
USE OF MELANOMA INHIBITORY ACTIVITY (MIA) PROTEIN AS AN EARLY INDICATOR FOR THERAPEUTIC RESPONSE IN MELANOMA
|
|
Assignee
|
|
|
LICHTSTRASSE 35 |
BASEL, SWITZERLAND 4056 |
|
Correspondence name and address
|
|
GEORGE R. DOHMANN
|
|
NOVARTIS PHARMACEUTICALS CORPORATION
|
|
ONE HEALTH PLAZA, BLDG 101
|
|
EAST HANOVER, NJ 07936
|
Search Results as of:
05/27/2024 12:18 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|